Equities researchers at Peel Hunt assumed coverage on shares of Chesnara (LON:CSN) in a report issued on Friday, ThisIsMoney.Co.Uk reports. The brokerage set a “reduce” rating and a GBX 290 ($3.79) price target on the stock. Peel Hunt’s price objective would suggest a potential downside of 18.31% from the stock’s previous close.

Separately, Shore Capital restated a “house stock” rating on shares of Chesnara in a report on Friday, March 29th.

Shares of LON CSN opened at GBX 355 ($4.64) on Friday. The company has a quick ratio of 13.54, a current ratio of 13.73 and a debt-to-equity ratio of 29.48. The firm has a market cap of $532.37 million and a PE ratio of 22.19. The stock has a fifty day moving average of GBX 346.20. Chesnara has a 52-week low of GBX 310.50 ($4.06) and a 52-week high of GBX 409.50 ($5.35).

In related news, insider David Rimmington sold 26,800 shares of Chesnara stock in a transaction on Tuesday, May 28th. The stock was sold at an average price of GBX 371 ($4.85), for a total value of £99,428 ($129,920.29).

Chesnara Company Profile

Chesnara plc, together with its subsidiaries, engages in life assurance and pension businesses primarily in the United Kingdom, the Netherlands, and Sweden. The company operates through CA, Movestic, Waard Group, and Scildon segments. It underwrites life risks, such as death, disability, health, and accident; and provides a portfolio of investment contracts for the savings and retirement needs of customers through asset management.

Further Reading: Asset Allocation and Your Retirement

Receive News & Ratings for Chesnara Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chesnara and related companies with MarketBeat.com's FREE daily email newsletter.